insights_auto
Why is MSCL up 3,95%?
Dive Deeperchevron_right
MSCL:TSE
Satellos Bioscience Inc
10,52 CA$
arrow_upward
+3,95%(+0,40) 1D
9 նոյ, 15:38:07 GMT-5 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MSCL...
Open
10,15 CA$
High
10,52 CA$
Low
9,99 CA$
Mkt. cap
224,98 մլն
Avg. vol.
11,40 հզր
Volume
9,73 հզր
52-wk high
18,98 CA$
52-wk low
7,56 CA$
EPS
-2,80 CA$
Beta
1,28
Shares outstanding
21,22 մլն
No. of employees
20
Open
10,15 CA$
High
10,52 CA$
Low
9,99 CA$
Mkt. cap
224,98 մլն
Avg. vol.
11,40 հզր
Volume
9,73 հզր
52-wk high
18,98 CA$
52-wk low
7,56 CA$
EPS
-2,80 CA$
Beta
1,28
Shares outstanding
21,22 մլն
No. of employees
20
News stories
From web sources and news partners
TradingView
·
5 ժամ առաջ
MSCL: BASECAMP’s Q1 2027 readout will test fat fraction as a potential accelerated-approval endpoint
Investing.com Canada
·
5 ժամ առաջ
Satellos Bioscience at Guggenheim: FDA path sharpens for DMD drug By Investing.com
Yahoo! Finance Canada
·
3 օր առաջ
Stocks in play: Satellos Bioscience Inc.
Investing.com
·
3 օր առաջ
Satellos changes primary endpoint in DMD trial after FDA talks
About Satellos Bioscience Inc
CEO-
Employees20
Founded2012
HeadquartersՎանքուվեր, Բրիտանական Կոլումբիա, Կանադա
SectorHealth Care
Industry-
Websitesatellos.com